Literature DB >> 10475192

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy.

B Vaidya, H Imrie, P Perros, J Dickinson, M I McCarthy, P Kendall-Taylor, S H Pearce.   

Abstract

Smoking and demographic variables are known to be risk factors for the development of thyroid-associated orbitopathy (TAO) among patients with Graves' hyperthyroidism, but a firm genetic basis for TAO has not been established. We show that the presence and severity of TAO are associated with an allele of the cytotoxic T lymphocyte antigen-4-gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475192     DOI: 10.1016/S0140-6736(99)01465-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Terry F Davies
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

2.  Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.

Authors:  Tereza Planck; Bushra Shahida; Marketa Sjögren; Leif Groop; Bengt Hallengren; Mikael Lantz
Journal:  Thyroid       Date:  2014-06-03       Impact factor: 6.568

3.  Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.

Authors:  Qin Zhang; Yun-mei Yang; Xue-ying Lv
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

Review 4.  Risk factors for development or deterioration of Graves' ophthalmopathy.

Authors:  Marius N Stan; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 5.  Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events.

Authors:  Elisa González-Rodríguez; Delvys Rodríguez-Abreu
Journal:  Oncologist       Date:  2016-06-15

6.  Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy.

Authors:  Le Min; Anand Vaidya; Carolyn Becker
Journal:  Eur J Endocrinol       Date:  2010-11-18       Impact factor: 6.664

7.  Intercellular adhesion molecule 1 gene polymorphisms do not contribute to Graves' disease in Chinese patients.

Authors:  Shu Wang; Hua Sun; Hao-Yan Chen; Ze-Fei Zhao; Yang Yang; Yong-Ju Zhao; Bin Cui; Guang Ning
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

Review 8.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

Review 9.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

Review 10.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.